文献速递真菌感染

美国曲霉病归因死亡分析:死亡证明数据2018-2024

Aspergillosis-Attributable Mortality in the United States: Analysis of Death Certificate Data.
PubMed 文献 · Clin Infect Dis · 2026-01-01

基于美国国家生命统计系统2018–2024年死亡证明数据,以ICD-10编码B44.x识别曲霉病归因死亡,计算年龄调整死亡率(AAMR)并按人口学分层。共识别7063例曲霉病归因死亡,AAMR为2.43(95%CI 2.37–2.49),其中22.0%死亡证明将曲霉病列为主要死因,近年AAMR高于2018–2020年。

要点

  • 仅22.0%的曲霉病死亡证明将其列为主要死因,多数为其他肺部曲霉病(B44.1)。
  • 近60%曲霉病死亡发生于≥65岁人群,近年AAMR范围2.50–3.01,高于2018–2020年的2.01。

核心结论

  • 死亡证明含曲霉病的患者中,主要归因死亡比例为22.0%;曲霉病归因死亡近年有所增加,结果有助于认识侵袭性曲霉病的真实流行病学。

主要发现

  • 共识别7063例曲霉病归因死亡,AAMR为2.43(95%CI 2.37–2.49);1551例(22.0%)死亡证明将曲霉病列为主要死因。
  • 侵袭性曲霉病(IA)编码最常见(4880份死亡证明),其中「其他肺部曲霉病」(B44.1)为4292份;未特指曲霉病2139份;非IA编码少见(73份)。
  • 近年AAMR范围为2.50–3.01,高于2018–2020年的2.01;近60%死亡发生于≥65岁人群,男性AAMR更高(RR 1.64,95%CI 1.50–1.80);种族和族裔与AAMR差异无关;各州AAMR存在差异。

关键数值与推荐

  • 曲霉病归因死亡定义:死亡证明任何位置列出ICD-10编码B44.x。

临床怎么用

  • 解读曲霉病死亡负担时需注意仅22.0%死亡证明将曲霉病列为主要死因,死亡证明数据可用于监测疾病负担与提高疾病认知。
  • 关注≥65岁人群和男性等AAMR较高群体,并结合各州差异评估本地曲霉病防控与诊断能力。

局限性

  • 原文摘要未报告死亡证明编码准确性验证、合并症具体结果及数据报告完整性的局限说明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The nationwide attributable mortality of aspergillosis in the era of mold-active triazoles is poorly understood. METHODS: We analyzed data from the US National Vital Statistics System for 2018-2024. Aspergillosis-attributable mortality was identified using an International Classification of Diseases-10th Revision (ICD-10) diagnosis code of B44.x listed anywhere on the death certificate. We present age-adjusted mortality rates (AAMRs)/1 000 000 persons with 95% confidence intervals (CIs) for aspergillosis deaths and stratified by demographics. Risk ratios (RRs) were used to compare AAMRs across strata and the proportion of key comorbidities included on aspergillosis versus non-aspergillosis certificates. RESULTS: There were 7063 aspergillosis-attributable deaths identified (AAMR: 2.43, 2.37-2.49). Of these, 1551 (22.0%) of death certificates had aspergillosis listed as the primary cause. An invasive aspergillosis (IA) disease code was most often listed (n = 4880 certificates); specifically, "other pulmonary aspergillosis" (B44.1, n = 4292 certificates). Unspecified aspergillosis was listed on 2139 death certificates. Non-IA codes were rarely observed (n = 73 certificates). Aspergillosis deaths increased in later years of analysis (AAMR range: 2.50-3.01) versus 2018-2020 (AAMR: 2.01). Nearly 60% of aspergillosis deaths occurred in those ≥65-years-old, and the AAMR was higher in males (RR: 1.64, 1.50-1.80). Neither race nor ethnicity was associated with differences in AAMR. AAMRs varied across states. CONCLUSIONS: Among patients with a death certificate with aspergillosis, primary attributable mortality was 22.0%. Our results may be useful as experts seek to better understand the true epidemiology of IA, develop efforts to raise disease awareness, and reduce IA-related mortality.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Walsh TJ, Sicignano D, Mastropietro M, et al. Aspergillosis-Attributable Mortality in the United States: Analysis of Death Certificate Data. Clin Infect Dis. 2026. PMID: 41284728. doi:10.1093/cid/ciaf653

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。